share_log

Barrington Research Reinstates Outperform on Cinemark Hldgs, Maintains $24 Price Target

Benzinga ·  May 6 10:38

Barrington Research analyst James Goss reinstates Cinemark Hldgs (NYSE:CNK) with a Outperform and maintains $24 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment